Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
#What Are The Current (2025) And Forecast (2029) Sizes Of The Hematopoietic Stem Cell Transplantation Market?
The hematopoietic stem cell transplantation market has recently seen strong growth. Its value is projected to rise from $4.68 billion in 2024 to $5.1 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 9.0%. The growth achieved historically can be attributed to several factors, including the development of early transplantation techniques, the initial state of limited indications and donor sources, continuous advancements in conditioning regimens, the increasing prevalence of allogeneic transplants, and significant regulatory milestones.
The hematopoietic stem cell transplantation market is anticipated to experience significant expansion in the coming years. This market is projected to reach $7.7 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 10.8%. The expansion during the forecast period is largely attributed to factors such as expanded treatment indications, donor source diversification, personalized medicine and genomics, regulatory changes and guidelines, as well as market expansion and accessibility. Key trends foreseen in this period encompass advancements in transplant techniques, broader expansion of indications, the emergence of new cellular therapies, further donor diversification, and a precision medicine approach.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10445&type=smp
What Are The Top Growth Drivers Impacting The Hematopoietic Stem Cell Transplantation Market Outlook?
The hematopoietic stem cell transplantation market is projected to grow due to the increasing prevalence of blood cancer, which encompasses malignancies that impair blood cell development and function, such as leukemia, lymphoma, and myeloma. Hematopoietic stem cell transplantation serves as a common treatment, replacing stem and bone marrow cells destroyed by the disease, allowing new cells to migrate to the bone marrow and produce fresh blood cells. This drives demand in the hematopoietic stem cell transplantation market. For instance, data shared by Blood Cancer UK in August 2022 revealed 41,000 new blood cancer cases are identified each year, establishing it as the sixth most prevalent malignancy in the UK. The condition is projected to affect approximately 250,000 people in the UK in 2022, impacting one in 16 men and one in 22 women during their lifetimes. Additionally, more than 500 children under the age of 15 are diagnosed with blood cancer annually, with pediatric leukemia accounting for 400 cases and lymphoma for 100. Thus, the escalating incidence of blood cancer is a primary factor propelling the hematopoietic stem cell transplantation market.
What Are The Major Segment Types Covered In The Hematopoietic Stem Cell Transplantation Market?
The hematopoietic stem cell transplantationmarket covered in this report is segmented –
1) By Type: Allogeneic; Autologous
2) By Indication: Leukemia; Lymphatic Disorder; Myeloma; Other Non-Malignant Disorders
3) By Application: Bone Marrow Transplant; Peripheral Blood Stem Cell Transplant; Cord Blood Transplant
4) By End User: Hospital Pharmacy; Retail Pharmacy; Specialty Clinics
Subsegments:
1) By Allogeneic: Matched Related Donor Transplantation; Matched Unrelated Donor Transplantation; Cord Blood Transplantation
2) By Autologous: Peripheral Blood Stem Cell Transplantation; Bone Marrow Stem Cell Transplantation
Which Ongoing Trends Are Expected To Shape The Hematopoietic Stem Cell Transplantation Market Outlook?
Product approvals are emerging as a significant trend within the hematopoietic stem cell transplantation market. Major companies operating in this market are increasingly adopting such approvals to solidify their market position. A notable example occurred in April 2022, when Priothera Ltd., an Ireland-based late-clinical stage biotechnology company, secured clearance from the United States Food and Drug Administration (FDA) for an investigational new drug (IND). This approval paved the way for commencing an allogeneic hematopoietic stem cell transplant (HSCT) Phase IIb/III research study using mocravimod in patients with acute myeloid leukemia (AML). Mocravimod, which is also known as KRP203, functions as a synthetic sphingosine 1-phosphate receptor (S1PR) modulator. Its safety, tolerability, and effectiveness for several autoimmune diseases have been previously evaluated through Phase I and Phase II trials.
Which Global Market Leaders Are Shaping The Future Of The Hematopoietic Stem Cell Transplantation Sector?
Major companies operating in the hematopoietic stem cell transplantation market include Pluristem Therapeutics Inc., Lonza Group AG, Escape Therapeutics Inc., Regen Biopharma Inc., Bluebird Bio Inc., CellGenix GmbH, CBR Systems Inc., Merck KGaA, Cord Blood Corporation, Kiadis Pharma NV, Marker Therapeutics Inc., Taiga Biotechnologies Inc., Takeda Pharmaceutical Company Limited, Talaris Therapeutics Inc., ViaCord LLC, ScienCell Research Laboratories Inc., BiolineRx, Stemcell Technologies Inc., ThermoGenesis Holdings Inc., MEDIPOST Co. Ltd., Anterogen. Co. Ltd., Pharmicell Inc., JCR Pharmaceuticals Co. Ltd., Holostem Terapie Avanzate Srl, Regrow Biosciences Pvt Ltd., Stempeutics Research Pvt Ltd.
Download The Full Report For Exclusive Market Findings:
What Are The Key Regional Factors Influencing The Hematopoietic Stem Cell Transplantation Market Growth?
North America was the largest region in the hematopoietic stem cell transplantation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global hematopoietic stem cell transplantation market during the forecast period. The regions covered in the hematopoietic stem cell transplantation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Request A Customized Version Of The Hematopoietic Stem Cell Transplantation Market Report:
https://www.thebusinessresearchcompany.com/customise?id=10445&type=smp
Browse Through More Reports Similar to the Global Hematopoietic Stem Cell Transplantation Market 2025, By The Business Research Company
Blood Glucose Meters Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/blood-glucose-meters-global-market-report
Blood Transfusion Diagnostics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report
Patient Blood Management Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/patient-blood-management-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model